![]()
|
|
||||||||
JBC, Vol. 250, Issue 21, 8293-8301, Nov, 1975
T. E. Hugli
C3a anaphylatoxin is derived from the third component (C3) of the blood
complement system. Selective proteolysis of C3 by activated proenzymes
indigenous to blood generates the C3a fragment. Human C3a was isolated from
inulin-activated serum containing 6-aminohexanoic acid, according to
recently published procedures (Hugli, T. E., Vallota, E., and
Muller-Eberhard, H. J. (1975) J. Biol. Chem. 250, 1472-1498). The human C3a
fragment is a highly cationic molecule exhibiting an approximate molecular
weight of 9000 and composed of 77 amino acid residues. It consists of a
single polypeptide chain containing 8% cysteine and lacks both tryptophan
and carbohydrate. A tentative primary structure for the human C3a molecule,
deduced from overlapping peptides obtained after cyanogen bromide cleavage,
tryptic and chymotryptic digestion, is: See article. Two cystelhylcysteine
sequences were established at positions 22, 23 and 56, 57 in human C3a. The
6 half-cystine residues in C3a are all interconnected through three
disulfide linkages intersecting in a disulfide knot. The functionally amino
acid residues distributed among 14 residues at the COOH-terminal end of
C3a. This unusually cationic COOH-terminal region of C3a is presumed to
play an important role in the interaction of this protein molecule with
cellular receptors. A comparison between the linear sequence of human C3a
and the NH2-terminal sequences of light and heavy chains of human
immunoglobulin indicates that limited identity exists.
Human anaphylatoxin (C3a) from the third component of complement. Primary structure
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Molina, J. Bunkenborg, G. H. Reddy, B. Muthusamy, P. J. Scheel, and A. Pandey A Proteomic Analysis of Human Hemodialysis Fluid Mol. Cell. Proteomics, May 1, 2005; 4(5): 637 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gao, H. Choe, D. Bota, P. L. Wright, C. Gerard, and N. P. Gerard Sulfation of Tyrosine 174 in the Human C3a Receptor Is Essential for Binding of C3a Anaphylatoxin J. Biol. Chem., September 26, 2003; 278(39): 37902 - 37908. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kawakami, Y. Shimoyama, and K. Ohtsuki Characterization of Complement C3 as a Glycyrrhizin (GL)-Binding Protein and the Phosphorylation of C3{alpha} by CK-2, Which Is Potently Inhibited by GL and Glycyrrhetinic Acid In Vitro J. Biochem., February 1, 2003; 133(2): 231 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ames, D. Lee, J. J. Foley, A. J. Jurewicz, M. A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K. F. Erhard, R. D. Cousins, et al. Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models J. Immunol., May 15, 2001; 166(10): 6341 - 6348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |